MG
Insider
Mark A Goldsmith
See RemarksMark A Goldsmith (See Remarks) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in Revolution Medicines, Inc. (RVMD). The largest single filing was $18.0M of RVMD (120,000 sh × $150.09, as filed), executed Apr 15.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
12
0 buys · 12 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$56.3M
shares × price, as filed
Last traded
Sep 16
Filed Sep 18
Median ADV $548.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $64.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
12 filings
Sector per market data · by filing · past 12 months
Most traded names
RVMDRecent filings
RVMDSALE
Revolution Medicines, Inc.
View filing →
$1.4M20,000 sh × $70.38
Exec Nov 18 2025
Filed Nov 20 2025 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $1.3M
20,000 sh × $65.07
Exec Nov 12 2025
Filed Nov 14 2025 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $1.8M
30,000 sh × $60.31
Exec Nov 7 2025
Filed Nov 12 2025 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $1.1M
20,000 sh across 2 lots
Exec Oct 16 2025
Filed Oct 20 2025 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $614K
13,411 sh × $45.82
Exec Sep 16 2025
Filed Sep 18 2025 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $538K
13,496 sh × $39.83
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $458K
11,738 sh × $39.04
Exec Mar 17 2025
Filed Mar 19 2025 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $532K
11,714 sh × $45.40
Exec Dec 16 2024
Filed Dec 18 2024 · 5:30 PM ET More filings →